CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-01 | WENDER JOSEPH H Director | Sale 10b5-1 | −16,800 | $65.50 | $1.1M | 92,035 |
| 2025-10-01 | Swayze Eric EVP Research | Option exercise 10b5-1 | +14,142 | $53.77 | $760K | 51,444 |
| 2025-10-01 | Swayze Eric EVP Research | Sale 10b5-1 | −14,142 | $66.09 | $935K | 37,302 |
| 2025-10-01 | Swayze Eric EVP Research | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −14,142 | 12,972 | ||
| 2025-09-30 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +14,827 | $56.78 | $842K | 71,957 |
| 2025-09-30 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −14,827 | $64.68 | $959K | 57,130 |
| 2025-09-30 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −14,827 | 30,203 | ||
| 2025-09-30 | Geary Richard S EVP, Chief Development Officer | Option exercise 10b5-1 | +57,900 | $53.77 | $3.1M | 137,557 |
| 2025-09-30 | Geary Richard S EVP, Chief Development Officer | Sale 10b5-1 | −57,900 | $65.24 | $3.8M | 79,657 |
| 2025-09-30 | Geary Richard S EVP, Chief Development Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −57,900 | 0 | ||
| 2025-09-30 | HOUGEN ELIZABETH L EVP, Finance & CFO | Option exercise 10b5-1 | +49,800 | $53.77 | $2.7M | 160,300 |
| 2025-09-30 | HOUGEN ELIZABETH L EVP, Finance & CFO | Sale 10b5-1 | −49,800 | $65.26 | $3.2M | 110,500 |
| 2025-09-30 | HOUGEN ELIZABETH L EVP, Finance & CFO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −49,800 | 0 | ||
| 2025-09-29 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +10,473 | $56.78 | $595K | 67,603 |
| 2025-09-29 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −10,473 | $64.54 | $676K | 57,130 |
| 2025-09-29 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −10,473 | 45,030 | ||
| 2025-09-12 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +1,700 | $56.78 | $97K | 58,830 |
| 2025-09-12 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −1,700 | $64.58 | $110K | 57,130 |
| 2025-09-12 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,700 | 55,503 | ||
| 2025-09-09 | Baroldi Joseph EVP, Chief Business Officer | Option exercise 10b5-1 | +11,950 | $31.80 | $380K | 43,876 |
Page 23 of 34 · 668 trades